ArticleThe Journal of clinical investigation2025

CAR-T cells targeting CD155 reduce tumor burden in preclinical models of leukemia and solid tumors.

Tianchen Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.